​

​

Three months ended

​

Year ended

​

​

March 31, 2026

​

December 31, 2025

​

​

Number of

​

Weighted

​

Weighted

​

Number of

​

Weighted

​

Weighted

​

​

Restricted

​

Average

​

Average

​

Restricted

​

Average

​

Average

​

​

Shares

​

Remaining Life

​

Grant Date

​

Shares

​

Remaining Life

​

Grant Date

​

  ​ ​ ​

Outstanding

  ​ ​ ​

(years)

  ​ ​ ​

Fair Value

  ​ ​ ​

Outstanding

  ​ ​ ​

(years)

  ​ ​ ​

Fair Value

Balance non-vested Restricted Stock at beginning of period

​

781,792

​

1.71

​

$

5.06

​

560,970

​

1.61

​

$

5.77

Granted

​

—

​

—

​

​

—

​

488,283

​

1.50

​

​

4.78

Vested

​

—

​

—

​

​

—

​

(267,461)

​

—

​

​

5.60

Balance non-vested Restricted Stock at end of period

​

781,792

​

1.46

​

$

5.06

​

781,792

​

1.71

​

$

5.06